ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Clinical trials for ADVANCED TRIPLE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED TRIPLE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for ADVANCED TRIPLE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to slow advanced breast cancer
Disease control Recruiting nowThis Phase II trial tests whether adding a PD-L1 antibody (adebrelimab) to a specific chemotherapy regimen (VEX) — with or without radiation — can delay cancer growth in people with advanced triple-negative breast cancer. About 150 participants will be randomly assigned to one of…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New cocktail of drugs hopes to tackle tough breast cancer
Disease control Recruiting nowThis phase II trial is testing a combination of three drugs—QL1706 (an immunotherapy), anlotinib (a targeted therapy), and nab-paclitaxel (chemotherapy)—as a first treatment for advanced triple-negative breast cancer. The study will enroll 34 women and aims to see if the combo ca…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for brain metastases? drug duo targets advanced cancers
Disease control Recruiting nowThis study tests whether combining two drugs, niraparib and dostarlimab, can control advanced cancers that have spread to the brain. It includes 120 adults with certain cancer types like BRCA-mutated or lung cancers. The goal is to see if the treatment shrinks or stabilizes brain…
Matched conditions: ADVANCED TRIPLE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC